Literature DB >> 21991276

The continuum of unipolar depression − bipolar II depression - bipolar I depression: different treatments indicated?

Willem A Nolen1.   

Abstract

Entities:  

Year:  2011        PMID： 21991276      PMCID： PMC3188771          DOI： 10.1002/j.2051-5545.2011.tb00054.x

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  8 in total

1.  Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

Authors:  R M Post; L L Altshuler; G S Leverich; M A Frye; W A Nolen; R W Kupka; T Suppes; S McElroy; P E Keck; K D Denicoff; H Grunze; J Walden; C M R Kitchen; J Mintz
Journal:  Br J Psychiatry       Date:  2006-08       Impact factor: 9.319

2.  A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).

Authors:  Susan L McElroy; Richard H Weisler; William Chang; Bengt Olausson; Björn Paulsson; Martin Brecher; Vasavan Agambaram; Charles Merideth; Arvid Nordenhem; Allan H Young
Journal:  J Clin Psychiatry       Date:  2010-01-26       Impact factor: 4.384

Review 3.  Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.

Authors:  Harm J Gijsman; John R Geddes; Jennifer M Rendell; Willem A Nolen; Guy M Goodwin
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

4.  Effectiveness of adjunctive antidepressant treatment for bipolar depression.

Authors:  Gary S Sachs; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael H Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245

5.  Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology.

Authors:  G M Goodwin
Journal:  J Psychopharmacol       Date:  2009-03-27       Impact factor: 4.153

6.  Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

Authors:  Mauricio Tohen; Eduard Vieta; Joseph Calabrese; Terence A Ketter; Gary Sachs; Charles Bowden; Philip B Mitchell; Franca Centorrino; Richard Risser; Robert W Baker; Angela R Evans; Karin Beymer; Sanjay Dube; Gary D Tollefson; Alan Breier
Journal:  Arch Gen Psychiatry       Date:  2003-11

7.  Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks.

Authors:  S N Ghaemi; A P Wingo; M A Filkowski; R J Baldessarini
Journal:  Acta Psychiatr Scand       Date:  2008-08-24       Impact factor: 6.392

Review 8.  Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.

Authors:  R W Licht; H Gijsman; W A Nolen; J Angst
Journal:  Acta Psychiatr Scand       Date:  2008-08-26       Impact factor: 6.392
  8 in total
  1 in total

1.  Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study).

Authors:  Young-Min Park; Bun-Hee Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-17       Impact factor: 2.570
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.